|
CTDSPL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.755400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.382400E-01 |
| Normal-vs-Stage2 |
8.399600E-01 |
| Normal-vs-Stage3 |
1.544230E-01 |
| Normal-vs-Stage4 |
2.754400E-02 |
| Stage1-vs-Stage2 |
8.375000E-01 |
| Stage1-vs-Stage3 |
1.165980E-02 |
| Stage1-vs-Stage4 |
8.247000E-04 |
| Stage2-vs-Stage3 |
2.816800E-01 |
| Stage2-vs-Stage4 |
1.263430E-01 |
| Stage3-vs-Stage4 |
4.192600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.494600E-01 |
| Normal-vs-AfricanAmerican |
2.618100E-03 |
| Normal-vs-Asian |
2.726400E-01 |
| Caucasian-vs-AfricanAmerican |
5.824500E-04 |
| Caucasian-vs-Asian |
3.722800E-01 |
| AfricanAmerican-vs-Asian |
1.931680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.290400E-01 |
| Normal-vs-Female |
7.648200E-01 |
| Male-vs-Female |
1.997650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.707600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.219400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.352400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.533600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.076600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.504600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.340600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.617610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.973600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.035200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.380250E-01 |
| Normal-vs-Grade 2 |
1.521960E-01 |
| Normal-vs-Grade 3 |
2.077200E-01 |
| Normal-vs-Grade 4 |
5.150400E-04 |
| Grade 1-vs-Grade 2 |
6.173400E-01 |
| Grade 1-vs-Grade 3 |
3.922200E-02 |
| Grade 1-vs-Grade 4 |
8.199100E-04 |
| Grade 2-vs-Grade 3 |
1.457200E-03 |
| Grade 2-vs-Grade 4 |
2.11549999962202E-07 |
| Grade 3-vs-Grade 4 |
5.120400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.720600E-03 |
| Normal-vs-ccB subtype |
1.222180E-01 |
| ccA subtype-vs-ccB subtype |
5.92689999967533E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.018000E-01 |
| Normal-vs-N1 |
1.870450E-01 |
| N0-vs-N1 |
2.410400E-01 |
|
|
